Healthcare | October 05, 2021
Amber Implants VCFix spinal system receives breakthrough designation
The first clinical trial is expected to commence in early 2022 both in Europe and the US
The first clinical trial is expected to commence in early 2022 both in Europe and the US
The consideration for the medicines in India is valued at Rs 180.48 crore
Lilly will continue to maintain its existing operating model for the remaining portfolio of products
Torrent is one of India's fastest-growing pharma majors
Global Health operates a network of four hospitals under the Medanta brand in Gurugram, Indore, Ranchi and Lucknow. In addition, one hospital is under construction in Patna, and another is planned for development in Noida
The AI-infused solution enables radiologists by fast triaging abnormalities in X-ray, annotating and automatic report generation with significantly improved performance
The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
This one-of-a-kind innovation challenge is aimed at addressing the challenges faced by healthcare providers in digital technology adoption
The acquisition complements and strengthens Merck’s cardiovascular pipeline
Subscribe To Our Newsletter & Stay Updated
